Skip to main content

Table 1 Demographics of users of hormonal contraceptive treatment (n = 62)

From: Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study

  CSP (n = 25)   SCI (n = 37)  
Variable Basal 4 months p Basal 4 months p
Age (years) 23.9 (18-32)* 23.9 (18-32) NA 28.0 (18-35)* 28.0 (18-35) NA
Weight (kg) 59.3 (42-90) 60.9 (47-88) 0.058 57.5 (36-91) 60.0 (39-101) 0.056
Height (m) 1.6 (1.5-1.7) 1.6 (1.5-1.7) NA 1.52 (1.38-1.64) 1.52 (1.38-1.64) NA
BMI (kg/m2) 24.6 (19.2-39) 25.3 (21.5-38.1) 0.062 24.7 (16.0-38.5) 25.8 (17.3-39.9) 0.062
AC (cm) 79 (62-110) 80.5 (64.0-109) 0.057 82 (58-101) 85.1 (60-109) 0.053
SBP (mmHg) 108 (90-120) 107 (100-120) 0.588 107 (90-120) 107 (90-120) 0.980
DBP (mmHg) 71 (60-80) 70 (60-80) 0.695 68 (60-80) 69 (68-80) 0.678
  1. Results are presented as mean (ranges). AC, abdominal circumference; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure. *p < 0.050 between basal contraceptive skin patch (CSP) vs. basal subdermal contraceptive implant (SCI).